Caterina Bissantz - Concepedia

Author

Caterina Bissantz

Roche (Switzerland)

Also Known As

Bissantz, Caterina, C Bissantz, C. BISSANTZ, C. Bissantz, Caterina Bissantz

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)ETH Zurich Hartford Financial Services (United States)Centre National de la Recherche Scientifique Hartford Hospital

About

Caterina Bissantz is an author at Roche (Switzerland) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.5K
2	Biochemistry	9	9	1.3K
3	Natural Sciences	8	8	1.3K
4	Engineering	3	3	157
5	Biomedical Engineering	1	1	49

Caterina Bissantz

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Protein-Based Virtual Screening of Chemical Databases. 1. Evaluation of Different Docking/Scoring Combinations Caterina Bissantz, Gerd Folkers, Didier Rognan Journal of Medicinal Chemistry Drug TargetHit IdentificationEstrogen ReceptorMolecular BiologyDifferent Docking/scoring Combinations	2000	732
Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? Caterina Bissantz, Philippe Bernard, Marcel Hibert, Proteins Structure Function and Bioinformatics Drug TargetMolecular BiologyMedicinal ChemistryChemical DatabasesMolecular Recognition	2002	296
Probing the Cysteine-34 Position of Endogenous Serum Albumin with Thiol-Binding Doxorubicin Derivatives. Improved Efficacy of an Acid-Sensitive Doxorubicin Derivative with Specific Albumin-Binding Properties Compared to That of the Parent Compound Felix Kratz, André Warnecke, Karin Scheuermann, Journal of Medicinal Chemistry	2002	271
A novel antibiotic class targeting the lipopolysaccharide transporter Claudia Zampaloni, Patrizio Mattei, Konrad Bleicher, Nature	2024	259
A Real-World Perspective on Molecular Design Bernd Kuhn, Wolfgang Guba, Jérôme Hert, Journal of Medicinal Chemistry Drug TargetHit IdentificationMolecular BiologyComputational ChemistryRoche Research Projects	2016	119
High-Throughput Modeling of Human G-Protein Coupled Receptors: Amino Acid Sequence Alignment, Three-Dimensional Model Building, and Receptor Library Screening Caterina Bissantz, Antoine Logean, Didier Rognan Journal of Chemical Information and Computer Sciences Drug TargetEngineeringComputer PackageMolecular BiologyThree-dimensional Model Building	2004	86
Safety screening in early drug discovery: An optimized assay panel Stefanie Bendels, Caterina Bissantz, Bernhard Fasching, Journal of Pharmacological and Toxicological Methods Drug SafetyPredictive ToxicologyPreclinical Drug EvaluationBioanalysisPharmacology	2019	78
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder Patrick Schnider, Caterina Bissantz, Andreas Bruns, Journal of Medicinal Chemistry	2020	60
Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators Linda Lundström, Caterina Bissantz, Jennifer Beck, British Journal of Pharmacology	2011	55
<i>In Vivo</i> Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model Marguerite L. Monogue, Sara Giovagnoli, Caterina Bissantz, Antimicrobial Agents and Chemotherapy	2018	51

Page 1